15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 14.9% per year over the past 5 years.
Operating margin has expanded, at -3.5% in the latest year.
Financial health
Total debt ($48M) exceeds cash ($36M); net debt is $13M.
Total debt has grown slower than revenue (8.6% vs 14.9% per year).
Operating income covered interest expense -1.0× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 12.1 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$225M
-$16M
74.3%
-3.5%
-$3M
$48M
$36M
2024
$187M
-$10M
75.8%
-1.8%
$1M
$47M
$28M
2023
$159M
-$22M
76.6%
-13.5%
-$20M
$47M
$31M
2022
$139M
-$29M
78.5%
-21.4%
-$36M
$46M
$15M
2021
$127M
-$27M
82.0%
-20.0%
-$41M
$45M
$33M
2020
$112M
-$24M
80.8%
-20.6%
-$32M
$32M
$49M
2019
$107M
-$29M
83.7%
-29.4%
-$25M
$0
$36M
2018
$84M
-$22M
84.6%
-24.4%
-$24M
$63000
$24M
2017
$60M
-$10M
84.6%
-13.2%
-$10M
$21M
$37M
2016
$41M
-$14M
84.3%
-19.8%
-$12M
$20M
$30M
2015
$27M
-$13M
82.3%
-33.9%
-$13M
$25M
$26M
2014
$17M
-$18M
79.5%
-58.3%
—
$25M
$8M
2013
$11M
-$15M
77.7%
-87.6%
—
$25M
$20M
2012
$8M
-$9M
74.5%
-101.4%
-$9M
$22M
$14M
2011
$5M
-$9M
50.0%
-143.7%
-$7M
$5M
$8M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$61M
-$20M
75.2%
-4.6%
-$1M
$0
$83M
Dec '25
$60M
-$13M
74.1%
-16.3%
$2M
$48M
$36M
Sep '25
$60M
$708000
76.6%
3.2%
$2M
$48M
$24M
Jun '25
$57M
$579000
74.2%
3.0%
$7M
$48M
$20M
Mar '25
$49M
-$4M
71.9%
-3.4%
-$13M
$48M
$18M
Dec '24
$49M
$450000
76.1%
4.1%
$8M
$47M
$28M
Sep '24
$49M
-$2M
74.9%
-0.6%
$3M
$47M
$19M
Jun '24
$48M
-$2M
73.8%
-0.9%
$3M
$47M
$19M
Mar '24
$41M
-$7M
78.8%
-11.0%
-$13M
$47M
$16M
Dec '23
$43M
-$4M
74.6%
-7.4%
-$2M
$47M
$31M
Sep '23
$41M
-$4M
76.8%
-9.8%
-$2M
$46M
$31M
Jun '23
$38M
-$7M
77.7%
-18.1%
-$4M
$46M
$23M
Mar '23
$37M
-$7M
77.7%
-20.0%
-$12M
$46M
$8M
Dec '22
$36M
-$5M
83.0%
-15.5%
-$5M
$46M
$15M
Sep '22
$37M
-$4M
83.3%
-13.1%
-$5M
$45M
$14M
Jun '22
$34M
-$8M
81.8%
-23.0%
-$10M
$45M
$12M
Mar '22
$31M
-$11M
82.1%
-36.5%
-$16M
$45M
$15M
Dec '21
$32M
-$5M
82.8%
-17.0%
-$9M
$45M
$33M
Sep '21
$31M
-$7M
83.2%
-21.4%
-$10M
$46M
$47M
Jun '21
$34M
-$8M
78.9%
-21.3%
-$9M
$46M
$53M
Valuation over time
How the market has priced AXGN against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 3.6× (Mar '23) to 10.5× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is AXGN growing its revenue and profit?
Over the past 5 years, Axogen, Inc.'s revenue has grown 14.9% per year. These are computed facts, not advice.
How much debt does AXGN have?
As of FY2025, Axogen, Inc. reported $48M of total debt against $36M of cash; operating income covered interest expense -1.0×.
What is AXGN's profit margin?
In FY2025, gross margin was 74.3%, operating margin -3.5%, and net margin -7.0%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.